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A cluster randomized controlled trial on a
multifaceted implementation strategy to
promote integrated palliative care in COPD:
study protocol of the COMPASSION study
Johanna M. C. Broese1,2* , Rianne M. J. J. van der Kleij1, Huib A. M. Kerstjens3, Els M. L. Verschuur2,
Yvonne Engels4 and Niels H. Chavannes1
Abstract
Background: Despite the urgent need for palliative care for patients with advanced chronic obstructive pulmonary
disease (COPD), it is not yet daily practice. Important factors influencing the provision of palliative care are adequate
communication skills, knowing when to start palliative care and continuity of care. In the COMPASSION study, we
address these factors by implementing an integrated palliative care approach for patients with COPD and their
informal caregivers.
Methods: An integrated palliative care intervention was developed based on existing guidelines, a literature review,
and input from patient and professional organizations. To facilitate uptake of the intervention, a multifaceted
implementation strategy was developed, comprising a toolbox, (communication) training, collaboration support,
action planning and monitoring. Using a hybrid effectiveness-implementation type 2 design, this study aims to
simultaneously evaluate the implementation process and effects on patient, informal caregiver and professional
outcomes. In a cluster randomized controlled trial, eight hospital regions will be randomized to receive the
integrated palliative care approach or to provide care as usual. Eligible patients are identified during hospitalization
for an exacerbation using the Propal-COPD tool. The primary outcome is quality of life (FACIT-Pal) at 6 months.
Secondary outcome measures include spiritual well-being, anxiety and depression, unplanned healthcare use,
informal caregiver burden and healthcare professional’s self-efficacy to provide palliative care. The implementation
process will be investigated by a comprehensive mixed-methods evaluation assessing the following
implementation constructs: context, reach, dose delivered, dose received, fidelity, implementation level, recruitment,
maintenance and acceptability. Furthermore, determinants to implementation will be investigated using the
Consolidated Framework for Implementation Research.
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Discussion: The COMPASSION study will broaden knowledge on the effectiveness and process of palliative care
integration into COPD-care. Furthermore, it will improve our understanding of which strategies may optimize the
implementation of integrated palliative care.
Trial registration: Netherlands Trial Register (NTR): NL7644. Registration date: April 7, 2019.
Keywords: COPD, Exacerbation, Proactive palliative care, Advance care planning, Quality of life, Integrated care,
Implementation study, Cluster randomized controlled trial
Background
Chronic Obstructive Pulmonary Disease (COPD) is a
common illness characterized by persistent respiratory
symptoms and airflow limitation [1]. When the disease
progresses, many patients experience recurrent acute
exacerbations, often requiring hospital admissions with a
mortality rate of up to 23% within 1 year after admission
[2]. COPD is the third leading cause of death in the
world [3]. Moreover, in advanced stages of the disease,
patients suffer from multiple symptoms, which are
frequently undertreated [4]. Accordingly, their health-
related quality of life is comparable to, or even worse
than that of patients with advanced lung cancer [5].
Thus, patients with COPD have at least a similar need
for palliative care.
In line with the WHO definition, palliative care should
not be restricted to reactive care in the terminal phase
of the disease [6]. Instead, it should be provided
proactively and earlier in the course of the disease,
complementing disease-modifying care. Its goal is to en-
hance quality of life through assessment and treatment
of physical, psychological, social and spiritual problems.
Additionally, it is advocated that palliative care should
take into account the maintenance of the patient’s
autonomy, access to information and treatment options
[7], which requires ongoing communication including
advance care planning and care coordination. In accord-
ance with current recommendations, palliative care
provision should principally be provided by generalist
care professionals, i.e. general practitioners and respira-
tory care specialists in the case of COPD-care, whereas
patients can be referred to specialist palliative care if
needed [7, 8]. Consequently, palliative care should be an
integrated part of regular COPD-care, in which profes-
sionals collaborate in multidisciplinary teams to optimize
continuity of care.
However, it is not yet clear how palliative care can be
successfully integrated into COPD-care. At the moment,
discussions on prognosis, goals of care and advance care
planning rarely occur or only at a very late stage of the
disease [9]. Neither are patients with COPD regularly
referred to specialist palliative care [10]. As a conse-
quence, patients with COPD are less likely to die at their
preferred place of death, and symptoms remain under-
treated [4, 11]. Previous research revealed three major bar-
riers to palliative care provision in COPD [9, 12]. First, the
unpredictable disease trajectory of COPD makes it diffi-
cult to determine when to start palliative care and discuss
advance care planning. The second barrier is the lack of
palliative care communication skills of professionals. The
third barrier is related to a lack of care continuity and
collaboration between healthcare professionals [12, 13].
In the COMPASSION (a central element in the
provision of COPD-care [13] and acronym for COPD
Palliative and Supportive care Implementation) study,
we attempt to overcome these barriers towards the
implementation of palliative care. In collaboration with
patient and professional organizations, we developed an
integrated palliative COPD care intervention that inte-
grates existing scientific and practical knowledge. More-
over, to facilitate uptake of the intervention among
healthcare professionals, a multifaceted implementation
strategy was developed comprising a training, an online
toolbox and support with planning and monitoring of
implementation.
In this article, we will describe the aim, design and
procedures of the COMPASSION study. Both the imple-
mentation process and clinical effectiveness of the inte-
grated palliative care approach will be assessed. The
COMPASSION study aims to:
1. investigate the effect of the implementation of
integrated palliative care on patient, informal
caregiver and healthcare professional outcomes;
2. investigate the effect of the multifaceted
implementation strategy on implementation
outcomes and explore what barriers hamper the
implementation of integrated palliative care in
routine COPD-care;
3. explore the relationship between implementation
level and patient outcomes.
Methods
Design
We follow an effectiveness-implementation hybrid
design type 2, as proposed by Curran et al. [14], which
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allows us to simultaneously test the implementation
strategy and impact of the integrated palliative care
intervention on health outcomes. To study effectiveness,
a cluster randomized controlled trial will be performed
in eight hospital regions in the Netherlands. Further-
more, the implementation process will be evaluated
using mixed methods. Each hospital region will serve as
a cluster. Randomization on this cluster level instead of
one-to-one randomization was chosen to reduce con-
tamination: it is likely that professionals exposed to the
implementation strategy also would treat patients
assigned to the control condition differently [15].
Setting
This study will take place in eight pulmonary care de-
partments of Dutch hospitals that collaborate with affili-
ated general practitioners, home care organizations and
palliative care consultation teams further referred to as




Each participating hospital region forms an intervention
group consisting of at least one of the following profes-
sions: pulmonologist, respiratory nurse of pulmonology
care department, palliative care consultant in the hos-
pital, general practitioner specialized in asthma and
COPD, general practitioner specialized in palliative care,
consultants from the regional palliative care consultation
teams. The following professionals can be involved facul-
tatively if present in that region: respiratory nurse in pri-
mary care, pulmonologists in training, practice nurse
and other relevant professionals.
Patients
Patients diagnosed with COPD and admitted to the
hospital for an acute exacerbation will be invited to
participate in the study. Patients not able to complete
questionnaires in Dutch, patients with severe cognitive
decline (e.g. dementia) and patients on the waiting list
for lung transplantation will be excluded. After comple-
tion of the baseline questionnaire, patients will be
screened using the Propal-COPD tool [16]. Patients with
a positive Propal-COPD score will be included in the ef-
fectiveness study. The Propal-COPD tool consists of
seven indicators: Medical Research Council (MRC) dys-
pnea score of 5, Clinical COPD Questionnaire (CCQ)
score > 3, forced expiratory volume in 1 s lower than
30% predicted, presence of specific comorbidities, body-
mass index lower than 21 kg/m2 or weight loss (> 10%
in the last 6 months or > 5% in last month), previous
hospitalization for acute exacerbation in the last 2 years
(last 2 years ≥2 admissions or last year ≥1 admission),
and a negative answer to the surprise question (“Will
you be surprised if your patient would die in the next
coming 12 months?”) [16]. For each indicator, specific
weight is given, together generating a total score. A
score exceeding the previous published cut off value of
− 1.362 corresponds with a high probability for death
within 1 year, which is considered a proxy for having
palliative care needs.
Informal caregivers
Informal caregivers of included patients will be invited
to participate by asking the patient to indicate who gives
him or her the most help and support at home.
Recruitment of regions
To recruit hospital regions for participation, invitational
letters will be sent to the heads of departments of re-
spiratory medicine of all hospitals in the Netherlands.
After agreement to take part in the study, eight hospital
regions will be selected for randomization to the inter-
vention or control group. Participating regions will be
offered a small reimbursement of expenses (maximum
€2.5 K per region).
Randomization
Hospital regions will be randomly allocated by an inde-
pendent statistician to the intervention or control condi-
tion, stratified by the number of COPD exacerbation
hospital admissions per year.
Blinding
To minimize response bias, patients and informal care-
givers will not be told whether their hospital is assigned
to the intervention or control group. Also, the researcher
will be blinded during the analysis process of effect
outcomes, using recoded identification numbers of
participants. Blinding of professionals for cluster group
allocation will not be possible due to the nature of the
implementation strategy and intervention. However,
professionals of control regions will be blinded for the
Propal-COPD score. As a consequence, it remains
unknown to them which patients take part in the effect-
iveness study and receive follow-up questionnaires.
Project organization
This study is part of a national project coordinated by
the Lung Alliance Netherlands, in cooperation with the
Leiden University Medical Center and the Radboud
University Medical Center, with financial support from
The Netherlands Organization for Health Research and
Development (ZonMw). A steering group for coordin-
ation and three expert groups is set up, representing the
relevant patient, family and professional organizations in
the Netherlands. In the development phase of the
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project, every 6 to 8 weeks meetings took place in which
the three expert groups gave input on (i) patient-
professional communication and compassionate care, (ii)
identification of palliative care needs and professional’s
expertise, and (iii) implementation and future dissemin-
ation, respectively. Additionally, existing practical tools
and useful links were selected for an online toolbox
supporting professionals.
Intervention
Table 1 details the components of the integrated pallia-
tive care approach, consisting of an integrated palliative
care intervention and an multifaceted implementation
strategy. Figure 1 shows the causal assumptions of its
outcomes and mechanisms of impact, based on the
Medical Research Council framework [26]. The inte-
grated palliative care intervention developed follows
existing palliative care guidelines [27, 28], the Quality
Framework Palliative care of the Netherlands [29], a
literature review and input from the expert groups. For
the identification of patients that are likely to benefit
from palliative care, the previously validated Propal-
COPD tool will be used. This tool has been validated in
patients admitted to the hospital for acute exacerbation
and showed to have a high sensitivity of 90% and specifi-
city of 73% [16]. Moreover, admission for an acute
exacerbation of COPD is considered to be one of the
key milestones for transition towards a palliative ap-
proach [30] and seems to be a feasible moment to start
proactive palliative care [31, 32]. After identification, one
or more consultations take place either in the outpatient
clinic or in the general practice, depending on the
patient’s needs, for a multidimensional assessment,
symptom management and advance care planning. The
treatment plan and agreements made will be docu-
mented and shared with other involved professionals
and discussed in a multidisciplinary meeting if needed.
In case of preference for care at home, the responsibility
will be transferred to the patient’s general practitioner. If
a patient deceases, the provided end-of-life care will be
evaluated with the patient’s informal caregiver and in-
volved healthcare professionals.
To facilitate the uptake of the integrated palliative care
intervention, an implementation strategy was developed
that consists of multiple components [17]. An online
toolbox describing the core elements of integrated pallia-
tive care and providing easy access to validated, existing
tools was established. Also, we developed an interactive
training including roleplay for participating healthcare
professionals. The training consists of two sessions of 3
h and addresses the core elements of integrated pallia-
tive care and its implementation. We collaborated with
experienced training actors whose training sessions have
been well received in previous research on advance care
planning in dementia [33]. Also, the adapted version of
the earlier developed Problems Square was used [18].
This tool is a practical translation of the WHO palliative
care definition and helps professionals structuring the
inventory of actual and possible future problems, and
needs and wishes across multiple dimensions. Further-
more, non-pharmacological and pharmacological dys-
pnea management was discussed. In the second training
session, each region collaboratively decides who should
be involved, and which steps need to be performed by
whom, how, where and when, leading to a regional ac-
tion plan. In this plan, the different steps of the patient
care process are elaborated (see Fig. 2). In order to guide
and monitor the implementation and execution of the
regional action plans, there will be regularly monitoring
meetings with the project leaders of each intervention
region. During the study period, every 4 months meet-
ings with participating professionals of the intervention
regions will take place in which experiences and recom-
mendations can be exchanged.
Following the recommendations of Mohr et al. [34],
we will not evaluate a locked-down version of the inter-
vention, but the implementation of the essential, core el-
ements of the integrated palliative care intervention that
will be responsible for the intervention effect. This
means that healthcare professionals of all participating
settings are allowed to fine-tune the intervention to
organizational, professional and patient characteristics.
This iterative refinement will result in continuous im-
provement of the intervention during the study period.
Similarly, small adaptations to the online toolbox can be
made based on incoming process evaluation data [34].
Control
Healthcare professionals of the control group will pro-
vide care as usual. For the Netherlands, this means that
all healthcare professionals have online access to all
existing guidelines on palliative care (including dyspnea)
and COPD, possibility to consult specialized palliative
care teams in primary care as well as in hospitals. After
the recruitment of participants has been completed, pro-
fessionals of the control group will be offered similar
training as the intervention group received, and they will
get access to the online toolbox.
Procedures
After randomization and formation of a regional inter-
vention team, participating professionals of all eight hos-
pital regions will be sent the baseline questionnaire by
email. This will be repeated 3 and 12 months after the
training (intervention regions) or the inclusion of the
first patient (control regions). A physician or nurse with
knowledge of the study will check all COPD-patients ad-
mitted to the pulmonology care department due to an
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acute exacerbation, and their informal caregiver if
applicable, for eligibility. After the informed consent
procedure, participating patients and informal caregivers
complete the questionnaires required for the Propal-
COPD tool and the baseline questionnaires during the
hospital stay. A physician or nurse will enter the Propal-
COPD tool indicators and baseline characteristics in an
online data management system. The system automatic-
ally calculates the Propal-COPD score, based on the
published algorithm [16]. For a patient of the
Table 1 Description of the implementation strategy and integrated palliative care intervention of the Compassion study
Implementation strategy




Multidisciplinary regional team Implementation strategies integrated into multiple




Website with information and guidance on the core elements of
palliative care in COPD, including tools and links for facultative use
Quality Framework [7]
Input from experts
Training session 1 (3
h)
Introductory information on the project and research n.a.
Instruction the Propal-COPD tool to identify the palliative phase in
patients with COPD
Propal-COPD tool [16]
Multidimensional assessment (physical, psychological, social,
spiritual)
Adapted version of Problems Square [18]
Communication training on advance care planning in COPD
including roleplay with actors
Training in palliative care communication with roleplay
supports implementation [19–21]
Non-pharmacological and pharmacological dyspnea management Breathing Thinking Functioning model [22]
Training session 2 (3
h)
Discussion current palliative care as organized in region vs. desired
palliative care
7-phase model [23]
Introductory information on implementing care pathway 7-phase model [23]
Filling in formats A to E (who does what how and when) leading
to first draft of regional action plan
Flowchart on patient care process (see Fig. 2)
Assigning local implementation leaders 7-phase model [23]
Completion of
regional action plan
Agreement on who does what how and when Format regional action plan
Action planning stimulates behavior change [24] and
assures the suitability of the intervention to the existing
structure of the region
Monitoring Monitoring meetings on site Audit and provide feedback to monitor, evaluate, and
modify provider behavior [25]
Evaluation meetings with local implementation groups Share local knowledge on how implementers and
clinicians made something work in their setting and then
share it with other sites [25]
Integrated palliative care intervention
Components Content of the component
Identification Calculation of Propal-COPD score
Planning first consultation with patient and informal caregiver
Multidimensional
assessment
Assessing palliative care needs on physical, psychological, social and spiritual dimension
Symptom
management
Non-pharmacological and pharmacological treatment for breathlessness and other physical symptoms, smoking cessation,
medication review, anxiety and depression
Advance care
planning




Individual care plan, documentation of advance care directives




Planning a consultation with informal caregiver to evaluate care in the last phase
Planning an evaluation of the provided palliative care with all involved professionals
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Fig. 1 Medical Research Council derived model [26] illustrating causal assumptions of outcomes and mechanisms of impact. Abbreviation PC:
palliative care
Fig. 2 Flowchart on the care process for the individual patient
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intervention region, the score will be displayed as “posi-
tive” or “negative” and in the control regions it will be
displayed as “xxx”. A patient with a positive Propal-
COPD score and, if present, his or her participating in-
formal caregiver, will be sent follow-up questionnaires 3
and 6months after inclusion. Questionnaires will be sent
on paper or digitally via email, depending on personal
preference. A flowchart of the cluster randomized con-
trolled trial is shown in Fig. 3.
Effect evaluation
An overview of the data collection process, detailing the
timing of data collection and the outcome measures and
instruments used, is provided in Table 2.
Primary effect outcome
The primary outcome is quality of life as measured with
the Functional Assessment of Chronic Illness Therapy-
Palliative care (FACIT-Pal) scale. This scale is a validated
46-item questionnaire comprising of a general part with
four subscales on physical well-being, social/family well-
being, emotional well-being and functional well-being,
respectively, and a specific part regarding palliative care
[35]. The total score ranges from 0 to 184; a higher score
indicates a better quality of life. Since a Dutch version of
the FACIT-Pal questionnaire was not yet available, the
items of the palliative care subscale were first translated
in collaboration with the FACIT organization, following
the FACIT translation/linguistic validation methodology
[44]. After a comprehensive forward-backwards transla-
tion process, the concept version of the translated FACI
T-Pal questionnaire was tested through retrospective
and cognitive interviews in ten patients: six with very se-
vere COPD, three with lung cancer and one with both
COPD and lung cancer. Recruitment of these patients
took place in a pulmonology ward, outpatient clinic, as
well as a pulmonary rehabilitation center.
Secondary effect outcomes
Secondary effect outcomes will be spiritual well-being,
disease-specific health-related quality of life, unplanned
healthcare use, date and place of death if applicable, in-
formal caregiver burden and professionals’ self-efficacy
and role identity with providing palliative care and dis-
cussing end-of-life. Satisfaction with care will be assessed
at the patient, informal caregiver and professional level.
The measurement instruments to be used are detailed in
Table 2.
Baseline measures
Demographic characteristics of patients that will be col-
lected are sex, age, ethnicity (western and non-western),
Fig. 3 Flowchart of procedures with timelines of (a) healthcare professionals and (b) patients and informal caregivers. Abbreviations HCP: health
care professionals; iT0: professional timeline at baseline (pre-implementation); iT3: 3 months after inclusion of first included patient (initial
implementation); iT12: 12 months after training (intervention regions) or inclusion of first patient (control regions) (late implementation); T0:
patient timeline at baseline; T3: patient timeline at 3 months; T6: patient timeline at 6 months; R: retrospectively
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marital status, living situation, an education level (high,
medium, low), smoking status, pack years. Also, charac-
teristics of disease severity (long term oxygen use, home
non-invasive ventilation use, previous ICU admissions,
previous mechanical ventilation and opioid use before
hospital admission) will be collected. Demographic char-
acteristics of informal caregivers that will be collected
are sex, age, education level (high, medium, low) and
current job. Demographic characteristics of professionals
that will be collected are function, years of experience,
palliative care experience and education.
Sample size calculation
Our primary outcome measure is quality of life mea-
sured with the FACIT-Pal. The clinically relevant differ-
ence is suggested to be between 4 to 6% of a measure’s
overall score for the Functional Assessment of Cancer
Therapy (FACT) scores, including the FACIT-Pal [45].
A previous systematic review on palliative care interven-
tions used the 5% midrange bound, which equals 9
points on the FACIT-Pal [46]. Assuming a standard de-
viation of 25 [47], at least 121 patients per group are re-
quired to obtain a power of 80% (two-sided t-test,
Table 2 Data collection schedule and measurement instruments for patients, informal caregivers and healthcare professionals
Measurement instrument
Patient T0 T3 T6 R
Baseline characteristics Questionnaire on demographic characteristics and case report form on disease
severity
x
Quality of life (primary outcome) Functional Assessment of Chronic Illness Therapy-Palliative care (FACIT-Pal) scale [35] x x x
Spiritual well-being Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being (FACIT-Sp-12)
scale [36]
x x x
Anxiety and depression Hospital Anxiety and Depression Scale (HADS) [37] x x x
Disease-specific health-related quality of
life
Clinical COPD Questionnaire (CCQ) x x x
Satisfaction with care Single item question on satisfaction with provided care, self-rated on a numeric rating
scale (NRS) from 0 to 10
x x
Unplanned healthcare use Medical record assessment on number of ED visits (without admission), hospital
admission (number and number of days), ICU admission (number and number of
days), in the 12 months pre-enrollment up to 12 months after enrollment
x
Date and place of death, place of care in
last week of life if applicable
Medical record assessment (and contact with general practitioner if needed) x
Dose received Questionnaire on received core elements, based on three validated questionnaires
[38–40]
x x
Medical record assessment on core elements x
Experiences and acceptability Semi-structured interviews xa
Informal caregiver T0 T3 T6
Baseline characteristics Questionnaire on demographic characteristics x
Caregiver burden Caregiver Reaction Assessment (CRA) scale [41] x x x
Satisfaction with care Single item question on satisfaction with provided care to the patient, self-rated on a
NRS from 0 to 10
x x
Experiences and acceptability Semi-structured interviews xa
Health care professional iT0 iT3 iT12
Self-efficacy End-of-life professional caregiver survey (EPCS) [42] x x x
Role identity Developed five-item question on role identity based on MIDI questionnaire [43] x x x
Satisfaction with care Single item question on satisfaction with provided palliative care to patients with
COPD, self-rated on a 5-point Likert scale
x x x




T0 patient timeline at baseline; T3 patient timeline at 3 months; T6 patient timeline at 6 months; R retrospectively; iT0 pre-implementation (professional timeline at
baseline); iT3 initial implementation (3 months after inclusion of first patient); iT12 = late implementation (12 months after training (intervention regions) or
inclusion of first patient (control regions))
a Interviews will be held with a purposeful sample of patients and informal caregivers between 3 and 6months after inclusion
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alpha = 0.05). To adjust for the clustering at hospital
level (a previous study found an ICC = 0.01 [32]) and to
allow for an additional loss to follow up of 10% a total of
347 patients are needed (44 patients per region).
Evaluation of the implementation process
In order to evaluate the implementation process and
detect barriers and facilitators, we will perform a com-
prehensive process evaluation. The following implemen-
tation constructs will be evaluated, as recommended by
Steckler and Linnan [48]: context, reach, dose delivered,
dose received, fidelity, implementation and recruitment.
Further, the constructs maintenance and acceptability
following recommendations of Proctor et al. will be eval-
uated. A combination of quantitative and qualitative
methods will be used. Various data on the implementa-
tion process will be collected: drafts of regional action
plans, field notes of training sessions, transcriptions of
monitoring meetings, project meetings and interviews
with implementation leaders and involved healthcare
professionals.
Implementation outcomes
Context refers to the larger physical, social, and political
environment that either directly or indirectly affects the
intervention. To study contextual characteristics of each
intervention region, we will use field notes of training
sessions, transcriptions of monitoring meetings, project
meetings and interviews with implementation leaders
and involved healthcare professionals.
Reach concerns the degree to which the intended
audience participates in the intervention. Reach of the
implementation strategy will be reported as the
composition of the intervention teams, the absolute
number and the proportion of professionals that par-
ticipated in the training, using the attendance list of
the training sessions. Reach of the intervention will
be reported as numbers, proportions and characteris-
tics of patients that received the integrated palliative
care intervention.
Dose delivered is measured as the extent to which core
elements of palliative care have been carried out by par-
ticipating healthcare professionals, using questionnaires
before and after the training. This measure reflects the
effect of the implementation strategy on the care prac-
tices of each professional.
Dose received is measured as the extent to which core
elements of palliative care are being received by partici-
pating patients, using patient questionnaires and medical
chart review on received core elements.
Fidelity refers to the extent to which a patient was
treated in accordance with the regional action plan.
Fidelity checklists for each participating intervention
patient will be filled out by the involved healthcare
professional.
Implementation is a composite score indicating the ex-
tent to which the intervention has been implemented by
professionals and received by patients. To compare the
integrated palliative care provision between the interven-
tion and control regions, the implementation score of
delivered and received core elements of integrated pallia-
tive care will be calculated using the calculation method
following Fleuren et al. [43].
Recruitment refers to the way we have recruited hos-
pital regions to become involved in the implementation
and evaluation of integrated palliative care in COPD.
Maintenance is the extent to which core elements of
integrated palliative care is embedded in the routine
organizational practices and policies.
Acceptability is the perception among healthcare pro-
fessionals, patients and informal caregivers that the inte-
grated palliative care intervention is agreeable, palatable,
or satisfactory. We will perform semi-structured inter-
views with involved healthcare professionals on their ex-
periences with the intervention and suggestions for
improvement. A purposeful sample of patients and in-
formal caregivers will be interviewed about their experi-
ences with and perceptions about the care received and
the information discussed with their healthcare profes-
sionals. Evaluation questionnaires will inquire on experi-
ences with the training and toolbox and suggestions for
improvement among participating professionals. The
data will be used to make adaptations to the training
and toolbox.
Barriers and facilitators to implementation
The Consolidated Framework For Implementation
Research will be used to explore what determinants to
implementation are across different contexts. This
framework consists of 37 constructs in five major
domains: intervention characteristics, outer setting, inner
setting, characteristics of the individuals involved, and
the process of implementation. We will use the
constructs to develop topic lists for semi-structured in-
terviews with involved professionals.
Data monitoring and management
All quantitative data will be collected using the online
data management system Castor edc. For the manage-
ment of participants, a secured Access database will be
used. In case of errors or essential missing data, the par-
ticipant or the concerning hospital will be contacted. Of
eligible non-consenting patients their year of birth, sex
and reasons for non-participation will be collected. The
qualitative data gathered via monitoring and project
meetings and interviews will all be audio-recorded and
transcribed verbatim. The transcripts will be
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pseudonymized. Also, field notes made during training
sessions and contact with professionals of the regions
will be written out in digital documents. All study data
and meta-data will be stored on a secured place in the
Leiden University Medical Center for 15 years.
Analysis
Analysis of effect evaluation
Data cleaning and all analyses will be carried out using
statistical software that supports multilevel mixed model
analyses, such as IMB SPSS Statistics 25. Baseline
characteristics of region and study population will be
analyzed using descriptive statistics. Continuous vari-
ables will be reported as mean and standard deviation
and categorical variables as frequency or percentage.
The statistical analyses will be done by an intention-to-
treat approach. All analysis will be considered significant
if α < 0.05. We will analyze differences between the con-
trol and the intervention group for the primary and sec-
ondary outcomes on the patient, informal caregiver and
professional level using multilevel mixed model analyses
that will account for the clustered study design (i.e. pa-
tients and professionals nested within a region). We will
check for eventual unbalances in baseline characteristics
and adjust for these variables if needed.
Analysis of process evaluation
All quantitative process data will be analyzed using de-
scriptive statistics. We will examine the association
between the implementation score and each effect out-
come measure at patient level, using linear regression
analysis. For this analysis, the dependent variable is the
implementation score. Independent variables are patient
outcomes at measurement point T6 or T12. Transcrip-
tions of the semi-structured interviews, monitoring ses-
sions and project meetings will be analyzed using
inductively and deductively content analysis techniques
supported by the qualitative analysis software Atlas.ti.
Subsequently, triangulation of quantitative and qualita-
tive results will take place.
Ethical considerations
The study has been approved by the Medical Ethics
Committee (CMO) of the Radboud University Medical
Centre (number 2018–4833). Since palliative care is add-
itional to disease-oriented care, we do not expect any
risks of participation for patients. The integrated pallia-
tive care intervention is patient-centred (adapted to the
needs of every individual patient) and based on existing
guidelines and thus could be considered as regular care.
However, participation in this study will require filling
out questionnaires which can be burdensome. To
minimize the burden, we therefore limited the length
and frequency of used questionnaires. Moreover, when
selecting and writing questionnaires and information
letters, we took into account that most patients are older
and have a low education level.
Discussion
This study protocol details the implementation and
evaluation of an integrated palliative care approach into
regular COPD-care in the Netherlands. The outcomes of
this large-scale study will add to the evidence base on
how to effectively implement palliative care for patients
with COPD, a study population which long has been
underrepresented in palliative care research [46].
The integrated palliative care approach was co-created
with a wide variety of stakeholders to incorporate
scientific and practical knowledge. Also, we built upon
previous experiences of national care pathway develop-
ment for patients admitted to the hospital for an acute
exacerbation COPD [49]. Moreover, since coordination
between different professionals and transmural collabor-
ation are vital requirements to provide good palliative
care, our approach integrates COPD-care and palliative
care and includes primary and secondary care
professionals.
The effectiveness of integrating palliative care into
regular COPD-care can only be tested when it is imple-
mented in a real-world setting. An ‘implementation
momentum’ had been created by the publication of the
Quality Framework for palliative care in 2017, prescrib-
ing the organization and provision of palliative care in
the Netherlands, independent of the type of disease [7].
Therefore, a hybrid study design which blends clinical
effectiveness and implementation research, as proposed
by Curran et al. [14], was chosen. A hybrid design might
enable a more rapid translation of our research findings
into routine practices, as it will provide information on
both the prerequisites of integrating palliative care in
routine COPD care and its clinical effectiveness. We are
planning to disseminate the study findings and promote
the scale-up of the approach if proven effective.
This study will have some methodological challenges.
In hybrid effectiveness-implementation studies, imple-
mentation science terminology and methods need to be
aligned to those of traditional, clinical effectiveness re-
search. Regarding the design, a complex balance needs
to be found between internal validity and factors that
promote implementation. In our study, to facilitate up-
take, the intervention will be tailored to regional needs.
Although this resembles real practice and enables
generalizability, the heterogeneity of provided interven-
tion elements to patients may limit internal validity.
Furthermore, all hospital regions – including those
randomized to the control group – wanting to partici-
pate in this study had a particular interest in this topic
and were eager to change their care practice. Hence, this
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might lead to smaller differences between the provided
care in the intervention and control group, and may de-
crease chances of detecting actual intervention effect.
We attempt to deal with this by measuring and compar-
ing the implementation score of delivered and received
core elements of integrated palliative care between inter-
vention and control groups.
Finally, it is uncertain what proportion of patients will
score positively on the Propal-COPD tool and thus will
be eligible for inclusion, as we made an assumption
based on the development study [16]. Although the
Propal-COPD tool is considered to be the best choice
because it showed high sensitivity, its robustness and its
feasibility in clinical practice need further testing. There-
fore, we are planning to perform external validation with
the data derived from this study.
Abbreviations
COPD: Chronic obstructive pulmonary disease; FACIT-Pal: Functional
Assessment Chronic Illness Therapy; Functional Assessment of Chronic Illness
Therapy-Palliative care; RCT: Randomized controlled trial
Acknowledgements
The authors would like to acknowledge all individuals representing the
organizations that were involved in the expert groups and gave feedback on
the core elements of the intervention and content of the online toolbox and
training. Also, the authors thank Jason Bredle of the FACIT organization for
the collaboration in the translation process of the FACIT-Pal questionnaire.
Furthermore, the authors wish to thank the patients that helped to pretest
the study questionnaires.
Authors’ contributions
The Lung Alliance Netherlands, NH, RK and YE initiated the project. JB, RK,
YE, NH and HK were involved in developing and refining the study design
and EV helped with the operationalization. JB wrote the first draft of the
manuscript. All authors drafted and revised sections of the manuscript and
contributed to the content. All authors read and approved the final
manuscript.
Funding
This work was financed by The Netherlands Organization for Health Research
and Development (ZonMw). This funding source had no role in the design
of this study and will not have any role during its execution, analyses,
interpretation of the data, or decision to submit results.
Availability of data and materials
Not applicable.
Ethics approval and consent to participate
The study has been approved by the Medical Ethics Committee (CMO) of
Radboud University Medical Centre (protocol number 2018–4833). After
receiving oral and written information about the study, participating patients
and informal caregivers are required to give their informed consent in
writing. On the informed consent form, participants indicate whether they
agree to be approached for an interview about their experiences with the
care they received. All participants of semi-structured interviews (patients, in-
formal caregivers and healthcare professionals) are given information on
interview procedures and data protection. Subsequently, they are required to




The authors declare that they have no competing interests.
Author details
1Public Health and Primary care, Leiden University Medical Centre, Post zone
V0-P, Postbox 9600, 2300 RC Leiden, The Netherlands. 2Lung Alliance
Netherlands, Amersfoort, The Netherlands. 3Department of Respiratory
Medicine and Tuberculosis, and Groningen Research Institute for Asthma and
COPD (GRIAC), University of Groningen and University Medical Centre
Groningen, Groningen, The Netherlands. 4Anaesthesiology, Pain and Palliative
Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.
Received: 17 July 2020 Accepted: 21 September 2020
References
1. GOLD. Pocket Guide to COPD Diagnosis, Management, and Prevention. A
Guide for Health Care Professionals 2017.
2. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related
factors after hospitalization for acute exacerbation of COPD. Chest. 2003;
124(2):459–67.
3. WHO. Fact Sheet Top 10 global causes of deaths, 2016: World Health
Organization; [updated 24 May 2018. Available from: http://www.who.int/
news-room/fact-sheets/detail/the-top-10-causes-of-death.
4. Janssen DJ, Spruit MA, Uszko-Lencer NH, Schols JM, Wouters EF. Symptoms,
comorbidities, and health care in advanced chronic obstructive pulmonary
disease or chronic heart failure. J Palliat Med. 2011;14(6):735–43.
5. Habraken JM, ter Riet G, Gore JM, Greenstone MA, Weersink EJ, Bindels PJ,
et al. Health-related quality of life in end-stage COPD and lung cancer
patients. J Pain Symptom Manag. 2009;37(6):973–81.
6. WHO. Definition Palliative care: World Health Organization; 2002 [Available
from: http://www.who.int/cancer/palliative/definition/en/.
7. IKNL/Palliactief. Netherlands Quality Framework for Palliative Care. 2017.
8. Lanken PN, Terry PB, Delisser HM, Fahy BF, Hansen-Flaschen J, Heffner JE,
et al. An official American Thoracic Society clinical policy statement:
palliative care for patients with respiratory diseases and critical illnesses. Am
J Respir Crit Care Med. 2008;177(8):912–27.
9. Tavares N, Jarrett N, Hunt K, Wilkinson T. Palliative and end-of-life care
conversations in COPD: a systematic literature review. ERJ Open Res. 2017;3:2.
10. Beernaert K, Cohen J, Deliens L, Devroey D, Vanthomme K, Pardon K, et al.
Referral to palliative care in COPD and other chronic diseases: a population-
based study. Respir Med. 2013;107(11):1731–9.
11. Cohen J, Beernaert K, Van den Block L, Morin L, Hunt K, Miccinesi G, et al.
Differences in place of death between lung cancer and COPD patients: a
14-country study using death certificate data. NPJ Prim Care Respir Med.
2017;27(1):14.
12. IKNL. Rapport IKNL Palliatieve zorg in beeld. 2014.
13. Oishi A, Murtagh FE. The challenges of uncertainty and interprofessional
collaboration in palliative care for non-cancer patients in the community: a
systematic review of views from patients, carers and health-care
professionals. Palliat Med. 2014;28(9):1081–98.
14. Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-
implementation hybrid designs: combining elements of clinical
effectiveness and implementation research to enhance public health
impact. Med Care. 2012;50(3):217–26.
15. Eccles M, Grimshaw J, Campbell M, Ramsay C. Research designs for studies
evaluating the effectiveness of change and improvement strategies. Qual
Safety Health Care. 2003;12(1):47–52.
16. Duenk RG, Verhagen C, Bronkhorst EM, Djamin RS, Bosman GJ,
Lammers E, et al. Development of the ProPal-COPD tool to identify
patients with COPD for proactive palliative care. Int J Chron Obstruct
Pulmon Dis. 2017;12:2121–8.
17. van Riet PJ, Vernooij-Dassen M, Sommerbakk R, Moyle W, Hjermstad MJ,
Leppert W, et al. Implementation of improvement strategies in palliative
care: an integrative review. Implement Sci. 2015;10:103.
18. Thoonsen B, Vissers K, Verhagen S, Prins J, Bor H, WC v, et al. Training
general practitioners in early identification and anticipatory palliative care
planning: a randomized controlled trial. BMC Fam Pract. 2015;16:126.
19. Back AL, Arnold RM, Baile WF, Fryer-Edwards KA, Alexander SC, Barley GE,
et al. Efficacy of communication skills training for giving bad news and
discussing transitions to palliative care. Arch Intern Med. 2007;167(5):453–60.
20. Hales BM, Hawryluck L. An interactive educational workshop to improve
end of life communication skills. J Contin Educ Heal Prof. 2008;28(4):241–8
quiz 9-55.
Broese et al. BMC Palliative Care          (2020) 19:155 Page 11 of 12
21. Thoonsen B, Gerritzen SH, Vissers KC, Verhagen S, WC v, Groot M, et al.
Training general practitioners contributes to the identification of palliative
patients and to multidimensional care provision: secondary outcomes of an
RCT. BMJ Support Palliat Care. 2016.
22. Spathis A, Booth S, Moffat C, Hurst R, Ryan R, Chin C, et al. The breathing,
thinking, functioning clinical model: a proposal to facilitate evidence-based
breathlessness management in chronic respiratory disease. NPJ Prim Care
Respir Med. 2017;27(1):27.
23. Aeyels D, Van der Veken L, Vanhaecht K. 7-fasenmodel voor de
ontwikkeling, implementatie, evaluatie en opvolging van zorgpaden.
Uitdieping voor transmurale zorg. Netwerk Klinische Paden: Leuven; 2016.
24. Hagger MS, Luszczynska A. Implementation intention and action planning
interventions in health contexts: state of the research and proposals for the
way forward. Appl Psychol Health Well-being. 2014;6(1):1–47.
25. Powell BJ, Waltz TJ, Chinman MJ, Damschroder LJ, Smith JL, Matthieu MM,
et al. A refined compilation of implementation strategies: results from the
expert recommendations for implementing change (ERIC) project.
Implement Sci. 2015;10:21.
26. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M.
Developing and evaluating complex interventions: the new Medical
Research Council guidance. BMJ (Clinical research ed). 2008;337:a1655.
27. IKNL. Richtlijn Dyspneu in de palliatieve fase 3.0. IKNL; 2015.
28. Nederland LA. Richtlijn Palliatieve zorg voor mensen met COPD. Amersfoort;
2011.
29. Boddaert M. Kwaliteitskader-Palliatieve-zorg-Nederland_IKNLPalliactief_2017;
2017.
30. Landers A, Wiseman R, Pitama S, Beckert L. Severe COPD and the transition
to a palliative approach. Breathe (Sheffield, England). 2017;13(4):310–6.
31. Buckingham S, Kendall M, Ferguson S, MacNee W, Sheikh A, White P, et al.
HELPing older people with very severe chronic obstructive pulmonary
disease (HELP-COPD): mixed-method feasibility pilot randomised controlled
trial of a novel intervention. NPJ Prim Care Respir Med. 2015;25:15020.
32. Duenk RG, Verhagen C, Bronkhorst EM, van Mierlo P, Broeders M, Collard SM,
et al. Proactive palliative care for patients with COPD (PROLONG): a pragmatic
cluster controlled trial. Int J Chron Obstruct Pulmon Dis. 2017;12:2795–806.
33. Tilburgs B, Koopmans R, Vernooij-Dassen M, Adang E, Schers H, Teerenstra
S, et al. Educating Dutch general practitioners in dementia advance care
planning: a cluster randomized controlled trial. J Am Med Dir Assoc. 2019.
34. Mohr DC, Schueller SM, Riley WT, Brown CH, Cuijpers P, Duan N, et al. Trials
of intervention principles: evaluation methods for evolving behavioral
intervention technologies. J Med Internet Res. 2015;17(7):e166.
35. Lyons KD, Bakitas M, Hegel MT, Hanscom B, Hull J, Ahles TA. Reliability and
validity of the functional assessment of chronic illness therapy-palliative care
(FACIT-pal) scale. J Pain Symptom Manag. 2009;37(1):23–32.
36. Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D. Measuring spiritual
well-being in people with cancer: the functional assessment of chronic
illness therapy--spiritual well-being scale (FACIT-Sp). Ann Behav Med. 2002;
24(1):49–58.
37. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta
Psychiatr Scand. 1983;67(6):361–70.
38. Uittenbroek RJ, Reijneveld SA, Stewart RE, Spoorenberg SL, Kremer HP,
Wynia K. Development and psychometric evaluation of a measure to
evaluate the quality of integrated care: the patient assessment of integrated
elderly care. Health expectations. 2016;19(4):962–72.
39. Heyland DK, D. P, P. D, F. L, You J.J. ea. The Development and Validation of
a Questionnaire to Audit Advance Care Planning. J Palliative Care Med.
2012;2(119).
40. Uijen AA, Schellevis FG, van den Bosch WJ, Mokkink HG, van Weel C, Schers
HJ. Nijmegen continuity questionnaire: development and testing of a
questionnaire that measures continuity of care. J Clin Epidemiol. 2011;
64(12):1391–9.
41. Nijboer C, Triemstra M, Tempelaar R, Sanderman R, van den Bos GA.
Measuring both negative and positive reactions to giving care to cancer
patients: psychometric qualities of the Caregiver Reaction Assessment (CRA).
Soc Sci Med (1982). 1999;48(9):1259–69.
42. Lazenby M, Ercolano E, Schulman-Green D, McCorkle R. Validity of the end-
of-life professional caregiver survey to assess for multidisciplinary
educational needs. J Palliat Med. 2012;15(4):427–31.
43. Fleuren MA, Paulussen TG, Van Dommelen P, Van Buuren S. Towards a
measurement instrument for determinants of innovations. Int J Qual Health
Care. 2014;26(5):501–10.
44. Eremenco SL, Cella D, Arnold BJ. A comprehensive method for the
translation and cross-cultural validation of health status questionnaires. Eval
Health Prof. 2005;28(2):212–32.
45. Ringash J, O'Sullivan B, Bezjak A, Redelmeier DA. Interpreting clinically
significant changes in patient-reported outcomes. Cancer. 2007;110(1):
196–202.
46. Kavalieratos D, Corbelli J, Zhang D, Dionne-Odom JN, Ernecoff NC, Hanmer J,
et al. Association between palliative care and patient and caregiver outcomes:
a systematic review and meta-analysis. Jama. 2016;316(20):2104–14.
47. Rogers JG, Patel CB, Mentz RJ, Granger BB, Steinhauser KE, Fiuzat M, et al.
Palliative Care in Heart Failure: the PAL-HF randomized, controlled clinical
trial. J Am Coll Cardiol. 2017;70(3):331–41.
48. Process evaluation for public health interventions and research. Steckler A,
Linnan L, editors. San Francisco, CA, US: Jossey-Bass; 2002. xxviii, 400-xxviii, p.
49. Westbroek LF, Klijnsma M, Salomé P, Sekhuis LM, Rolink E, Korsmit E, et al.
Reducing the number of hospitalization days for COPD: setting up a
transmural care pathway Int J Chron obstruct Pulmon dis. Forthcoming.
2020.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Broese et al. BMC Palliative Care          (2020) 19:155 Page 12 of 12
